Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).
Bodensohn R, Fleischmann DF, Maier SH, Anagnostatou V, Garny S, Nitschmann A, Büttner M, Mücke J, Schönecker S, Unger K, Hoffmann E, Paulsen F, Thorwarth D, Holzgreve A, Albert NL, Corradini S, Tabatabai G, Belka C, Niyazi M. Bodensohn R, et al. Among authors: tabatabai g. Clin Transl Radiat Oncol. 2023 Dec 3;45:100706. doi: 10.1016/j.ctro.2023.100706. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38116137 Free PMC article.
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
Maier SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A, Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W, Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A, Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn R. Maier SH, et al. Among authors: tabatabai g. Clin Transl Radiat Oncol. 2024 May 4;47:100790. doi: 10.1016/j.ctro.2024.100790. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38765202 Free PMC article.
Criteria for Re-Irradiation.
Willmann J, Andratschke N, Klußmann JP, Gschwend JE, Tabatabai G, Niyazi M. Willmann J, et al. Among authors: tabatabai g. Dtsch Arztebl Int. 2024 Nov 1;121(22):725-732. doi: 10.3238/arztebl.m2024.0156. Dtsch Arztebl Int. 2024. PMID: 39194170 Free article. Review.
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A; International Consortium on Meningiomas; Zadeh G, Aldape KD. Nassiri F, et al. Among authors: tabatabai g. Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061. Neuro Oncol. 2019. PMID: 31158293 Free PMC article.
Development and validation of a molecular classifier of meningiomas.
Landry AP, Wang JZ, Liu J, Patil V, Gui C, Patel Z, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chotai S, Chambless LB, Rebchuk AD, Makarenko S, Yip S, Mansouri A, Tsang DS, Aldape K, Gao A; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G. Landry AP, et al. Among authors: tabatabai g. Neuro Oncol. 2025 Jan 8:noae242. doi: 10.1093/neuonc/noae242. Online ahead of print. Neuro Oncol. 2025. PMID: 39775867
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial.
Malmström A, Oppong FB, O Callaghan CJ, Wick W, Laperriere N, Gorlia T, Weller M, Henriksson R, Mason W, Platten M, Cantagallo E, Grønberg BH, Reifenberger G, Marosi C, Perry JR; NCBTSG, NOA, CCTG and EORTC Brain Tumor Group. Malmström A, et al. Neurooncol Adv. 2024 Dec 4;6(1):vdae211. doi: 10.1093/noajnl/vdae211. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39759261 Free PMC article.
Genome-wide CRISPR-Cas 9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma.
Haeusser LA, Becker H, Kuhlburger L, Zago M, Walter B, Tsiami F, Erdmann S, Trampert J, Surender S, Stahl A, Templin M, Wegner E, Schmidt T, Schmees C, Casadei N, Sevenich L, Claassen M, Nahnsen S, Beck S, Merk DJ, Tabatabai G. Haeusser LA, et al. Among authors: tabatabai g. Neuro Oncol. 2025 Jan 4:noae278. doi: 10.1093/neuonc/noae278. Online ahead of print. Neuro Oncol. 2025. PMID: 39756423
Functional screening reveals genetic dependencies and diverging cell cycle control in atypical teratoid rhabdoid tumors.
Merk DJ, Tsiami F, Hirsch S, Walter B, Haeusser LA, Maile JD, Stahl A, Jarboui MA, Lechado-Terradas A, Klose F, Babaei S, Admard J, Casadei N, Roggia C, Spohn M, Schittenhelm J, Singer S, Schüller U, Piccioni F, Persky NS, Claassen M, Tatagiba M, Kahle PJ, Root DE, Templin M, Tabatabai G. Merk DJ, et al. Among authors: tabatabai g. Genome Biol. 2024 Dec 2;25(1):301. doi: 10.1186/s13059-024-03438-w. Genome Biol. 2024. PMID: 39617889 Free PMC article.
223 results